TruScreen offers the latest technology in cervical screening, providing real-time, accurate detection of pre-cancerous and cancerous cervical cells to help improve the health and wellbeing of women around the world.
TruScreen’s world-class technology has the power to save lives
TruScreen® is a cost-effective test that can be used outside existing laboratory infrastructure and has high potential to aid in reducing cervical cancer mortality. This new technology detects pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. The system uses low levels of electricity and light to examine the cervix as a hand-held wand is gently moved over the surface of the cervix.
Unlike the Pap test, tissue samples are not collected, which minimises discomfort for patients. TruScreen® has been extensively evaluated in studies involving more than 10,000 women worldwide, and it has been proven as, or more, effective than top quality conventional Pap tests.